MRNA position history
The shares of Moderna (MRNA) that Murphy Pohlad Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 2,215 shares, $261K, 0.12% of portfolio, New
- 2022 Q4: 2,215 shares, $398K, 0.16% of portfolio
- 2023 Q1: 2,215 shares, $340K, 0.14% of portfolio
- 2023 Q2: 2,215 shares, $269K, 0.12% of portfolio
- 2023 Q3: 2,000 shares, $207K, 0.09% of portfolio, Reduce −9.7%
- 2023 Q4: 2,050 shares, $204K, 0.08% of portfolio, Add +2.5%
- 2024 Q1: 2,000 shares, $213K, 0.08% of portfolio, Reduce −2.4%
- 2024 Q2: 2,000 shares, $238K, 0.10% of portfolio
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: not held
- 2026 Q2: 3,824 shares, $268K, 0.09% of portfolio, New
- 2026 Q3: 3,324 shares, $640K, 0.22% of portfolio, Reduce −13.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|